ÂÜÀòÂÒÂ×

Mahesh Raundhal is a Principal Scientist with experience in leading research efforts in various prestigious organizations such as Sanofi, Jnana Therapeutics, and Dana-Farber Cancer Institute. They have a strong background in immunology and have made significant contributions to the field by identifying novel functions for certain enzymes and developing innovative workflows to identify potential treatments for various diseases. Their work has focused on areas like immune inflammation, cancer immunosuppression, and mechanisms of immune tolerance. Raundhal holds a PhD in Immunology from the University of Pittsburgh and has a Master's and Bachelor's degree in Biotechnology from the University of Mumbai.